Reuters logo
BRIEF-Amag Pharmaceuticals Q3 loss per share $4.31
November 2, 2017 / 11:44 AM / in 21 days

BRIEF-Amag Pharmaceuticals Q3 loss per share $4.31

Nov 2 (Reuters) - Amag Pharmaceuticals Inc

* Amag Pharmaceuticals announces third quarter 2017 financial results and business highlights

* Q3 loss per share $4.31

* Q3 earnings per share view $0.18 -- Thomson Reuters I/B/E/S

* Q3 revenue $153.7 million versus I/B/E/S view $168.5 million

* Amag Pharmaceuticals Inc - ‍co has updated 2017 Makena revenue guidance to between $385 million and $395 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below